3652 results for «303»
3652 results
Challenging femoral access and alternative access
03 Mar 2023 – From AfricaPCR 2023
In this session, learn about femoral artery dissection after TAVI, femoral perforation, alternative access for TAVI, and follow discussions about the safest way to perform transfemoral access, among others!
Coronary clinical cases - session 2
03 Mar 2023 – From AfricaPCR 2023
This session combines several cases including a case of type V STEMI secondary to calcium embolism during SAVR, another case of failed coronary artery bypass grafting, a third case of coronary artery dissection and a last case where imaging is essential to determine whether it is...
Coronary clinical cases - session 1
03 Mar 2023 – From AfricaPCR 2023
This AfricaPCR 2023 session will enable you to study several cases, including that of a 66-year-old male patient with atrial fibrillation, hypothyroidism, previous PCI of RCA, LM to LAD and OM, who was admitted for NSTEMI. Watch the video to find out more!
Navigating the complexities of contemporary private practice
03 Mar 2023 – From AfricaPCR 2023
Watch this AfricaPCR 2023 session to learn the basic principles about private practice set up, become familiar with the administrative tools available and regulatory environment governing practice, and understand the importance of institutional, clinical and peer networks in private practice.
The importance of IVUS in optimising PCI of the left main coronary artery
03 Mar 2023 – From AfricaPCR 2023
Watch the case of an 89-year-old active male patient with type II diabetes and pulmonary hypertension, awaiting hip replacement, who presented with recently worsening effort dyspnoea, and review his treatment management thanks to the recorded video while following the debate around such intervention.
Valvular clinical cases
04 Mar 2023 – From AfricaPCR 2023
Watch this session of AfricaPCR 2023 to discover, among others, a case of MViV, an upper limb TAVI combined with PVD intervention, transfemoral TAVI and TMVR in severe native valve disease, or even a bailout TAVI.
How should I treat a patient with multivessel disease - A patient's journey
04 Mar 2023 – From AfricaPCR 2023
In this session, study the case of a 55-year-old female patient with DM and previous inferior STEMI, who presented with minimal exertion angina, 48% EF and mild MR, and follow her journey to understand how to optimally handle the specifics of patients with multivessel disease.
Calcified left main bifurcation PCI: how to evaluate and how best to treat - LIVE case
04 Mar 2023 – From AfricaPCR 2023
A 62-year-old male with hormonal treatment (metastatic prostate carcinoma) presents an exertion angina due to an MVD: severe calcified stenoses of distal left main (medina 1-1-1), mid LAD and prox CX.
Watch how the operators prepare LAD and CX lesions with Rotablator (Burrs: 1.25 + 1.75) then...
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
